Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.06
+0.09 (1.36%)
At close: May 9, 2025, 4:00 PM
7.38
+0.33 (4.61%)
After-hours: May 9, 2025, 7:49 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 103 employees as of December 31, 2024. The number of employees decreased by 130 or -55.79% compared to the previous year.
Employees
103
Change (1Y)
-130
Growth (1Y)
-55.79%
Revenue / Employee
n/a
Profits / Employee
$708,262
Market Cap
61.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MCRB News
- 3 days ago - Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 11 days ago - Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases - GlobeNewsWire
- 17 days ago - Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025 - GlobeNewsWire
- 2 months ago - Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025 - GlobeNewsWire
- 2 months ago - Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach - GlobeNewsWire